BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 1336650)

  • 1. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of in situ cancer.
    Recht A; Connolly JL; Schnitt SJ; Harris JR
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current controversies in the treatment of ductal carcinoma in situ of the breast.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
    Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive carcinoma of the breast: the rationale for various treatment options.
    Kuske RR
    J La State Med Soc; 1994 Apr; 146(4):128-32. PubMed ID: 8006495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 10. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation.
    Silverstein MJ; Lagios MD
    J Surg Oncol; 2007 Jun; 95(8):605-9. PubMed ID: 17192948
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast conservation therapy in the management of invasive and in situ carcinoma.
    Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
    R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
    Vrouenraets BC; Peterse JL; van Dongen JA
    Neth J Surg; 1991 Jun; 43(3):51-5. PubMed ID: 1656327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
    Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
    Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
    Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM
    Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
    Bradley SJ; Weaver DW; Bouwman DL
    Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ductal carcinoma in situ of the breast.
    Moore MM
    Semin Surg Oncol; 1991; 7(5):267-70. PubMed ID: 1663649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.